GMAB

Genmab AS is a leading biotechnology firm headquartered in Copenhagen, Denmark, specializing in the creation of differentiated antibody therapeutics for oncology and other severe diseases. Renowned for its innovative approach and cutting-edge proprietary technologies, the company has established a robust pipeline of next-generation therapies through strategic alliances and collaborations. With a steadfast focus on enhancing patient outcomes via targeted immunotherapies, Genmab is strategically positioned to leverage growth opportunities within the evolving oncology landscape, making it an attractive prospect for institutional investors.